Resultados de la búsqueda 21-30 of 9569 for Enzyme

1. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

   Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells ...

2. Aumento de enzimas hepáticas When to see a doctor - Mayo Clinic

   El boletín informativo de Mayo Clinic en español es gratuito y se envía semanalmente por correo electrónico con consejos de salud, recetas deliciosas, ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps ...

4. Aumento de enzimas hepáticas When to see a doctor - Mayo Clinic

   17, 2020. Jan. 06, 2022. Original article: https://www.mayoclinic.org/es/symptoms/elevated-liver-enzymes/basics/when-to-see-doctor/sym-20050830 . Mayo ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide, work in ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

8. Bloqueantes de los receptores de la angiotensina II - Mayo Clinic

   Major side effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. https://www.uptodate.com/contents/search. Accessed ...

9. Cirugía - Ensayos clínicos - Mayo Clinic

   Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...